Company & Sponsor Intelligence

University of Arizona

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting1

Completed5

Countries1

Therapeutic footprint

adhddementia_otherdepressionother_neurologyparkinsons

Indexed studies

NCT04934371Treatment of Tinnitus With Noninvasive Neuromodulation and Listening Therapy
other_neurology · United StatesNA

NCT04932447Breathing Training for Improving Cardiovascular Health in Older Adults With Sleep Apnea
other_neurology · United StatesNA

NCT00517504Methylphenidate Study in Young Children With Developmental Disorders
adhd · PHASE4

NCT07423923Representation of Spatiotemporal Information in Human Episodic Memory and Navigation
other_neurology · United StatesEARLY_PHASE1

NCT03652012Probing Cortical Excitability and Cognitive Function With TMS
dementia_other · United StatesNA

NCT02556164Electro-acupuncture for Gait and Balance in Parkinson's Disease
parkinsons · NA

NCT00517972Omacor for Perimenopausal Depression
depression · United StatesPHASE2

NCT03685279Efficacy of the Nurtured Heart Approach to Reduce ADHD Behaviors in Children
adhd · United StatesNA

NCT00517647Atomoxetine Pilot Study in Preschool Children With ADHD
adhd · United StatesPHASE4

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →